Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Submit for the Fierce Pharma Marketing Awards - Deadline ends this Friday, July 3rd
cell therapy
Manufacturing
Cellares, Ori dominate automated cell therapy production: report
The bulk of the field’s raised capital (81%) is held by Cellares and Ori Biotech, Tracxn said in a new report.
Fraiser Kansteiner
Jun 18, 2026 10:10am
Bayer diagnoses how to build trust in cell and gene therapies
May 6, 2026 10:45am
With ‘lessons learned,’ Kite preps for key CAR-T launch
Apr 28, 2026 11:30am
J&J drafts designs for $1B cell therapy plant in Pennsylvania
Feb 18, 2026 11:23am
Fierce Biotech
Charles River to close Maryland CDMO site, lay off 20 staffers
Feb 3, 2026 12:20pm
Fierce Biotech
AstraZeneca vows $15B China investment to boost R&D capabilities
Jan 29, 2026 5:50am
